Document is current
Any future updates will be listed below
-
Authors
Santos, Ana R.
Lopes, Marta
Santos, Torcato
Reste-Ferreira, Débora
Marques, Inês P.
Yamaguchi, Taffeta C. N.
Miranda, Telmo
Mendes, Luís
Martinho, António C. V.
Pearce, Liz
Cunha-Vaz, José https://orcid.org/0000-0002-0947-9850
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05112445 at ClinicalTrials.govDocuments that mention this clinical trial
Intraretinal Microvascular Abnormalities in Eyes with Advanced Stages of Nonproliferative Diabetic Retinopathy: Comparison Between UWF-FFA, CFP, and OCTA—The RICHARD Study
https://doi.org/10.1007/s40123-024-01054-2
-
Funding
Funding for this research was provided by:
Boehringer Ingelheim GmBH
- License Information
-
More Information
Article History
Received: 24 June 2024
Accepted: 4 October 2024
First Online: 26 October 2024
Declarations
:
: Ana R Santos, Marta Lopes, Torcato Santos, Débora Reste-Ferreira, Inês P Marques, Telmo Miranda, Luís Mendes and António CV Martinho declare there are no conflicts of interest. Taffeta CN Yamaguchi is a Boehringer Ingelheim employee. Liz Pearce previously worked at Boehringer Ingelheim, participated in the design of the study. José Cunha-Vaz reports grants from Bayer, Boehringer Ingelheim and Carl Zeiss Meditec and is a consultant for Alimera Sciences, Bayer, Boehringer Ingelheim, Carl Zeiss Meditec and Roche. José Cunha-Vaz is an Editorial Board member of<i> Ophthalmology and Therapy</i>. José Cunha-Vaz was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.
: The tenets of the Declaration of Helsinki were followed, and approval was obtained from the AIBILI Ethics Committee for Health (CE 240 RICHARD), and the trial was registered at ClinicalTrials.gov, identifier NCT05112445. Written informed consent was obtained by each participant agreeing to participate in the study.
